Unichem Laboratories to appeal the decision of European Commission

  • Posted on: 10 July 2014
  • By: PharmaTutor News

Pharma Admission

Pharma courses

pharma admission

pharma courses

(10th July, 2014); On 9th July 2014, the European Commission (the EU’s top competition regulator) decided to impose a wholly unjustified fine on Niche /Unichem (jointly and severally) contending that it had acted in breach of EU Antitrust Rules. The European Commission reached this conclusion because its subsidiary, Niche Generics Ltd (Niche), agreed to settle financially crippling patent litigation with Laboratories Servier (Servier) at the beginning of 2005.

Unichem vehemently denies any wrongdoing on the part of either itself or Niche. Moreover, Unichem was not involved in the agreement to settle the litigation with Servier back in 2005 as it only took full ownership of Niche late in 2006. Unichem cannot in any way see how it can be held accountable for what was in any event a pro-competitive act on the part of its then only part-owned subsidiary Niche.

Unichem will vigorously appeal the European Commission decision to the EU courts and seek to attain the correct result in this matter a result which is in the best interests of the consumer. While Unichem presses ahead with its intention to have the European Commission’s decision overturned it intends to carry on its business as usual.

Subscribe to PharmaTutor News Alerts by Email >>


Latest News